Skip to content
← Back to this collection

PUBLICATIONS · 29863979

PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2018 Jul 26
First author
Migden MR

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Aug;15(8):472. doi: 10.1038/s41571-018-0056-5.
    note
    Source null
    related pmid
    29921845
    relationship
    Comment in
  2. citation
    Eye (Lond). 2023 Aug;37(12):2482-2487. doi: 10.1038/s41433-022-02358-y.
    note
    Source null
    related pmid
    36690728
    relationship
    Comment in

Authors and identifiers

  1. name
    Migden MR
    type
    Author
  2. name
    Rischin D
    type
    Author
  3. name
    Schmults CD
    type
    Author
  4. name
    Guminski A
    type
    Author
  5. name
    Hauschild A
    type
    Author
  6. name
    Lewis KD
    type
    Author
  7. name
    Chung CH
    type
    Author
  8. name
    Hernandez-Aya L
    type
    Author
  9. name
    Lim AM
    type
    Author
  10. name
    Chang ALS
    type
    Author
  11. name
    Rabinowits G
    type
    Author
  12. name
    Thai AA
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Migden MR
    type
    Author
  2. name
    Rischin D
    type
    Author
  3. name
    Schmults CD
    type
    Author
  4. name
    Guminski A
    type
    Author
  5. name
    Hauschild A
    type
    Author
  6. name
    Lewis KD
    type
    Author
  7. name
    Chung CH
    type
    Author
  8. name
    Hernandez-Aya L
    type
    Author
  9. name
    Lim AM
    type
    Author
  10. name
    Chang ALS
    type
    Author
  11. name
    Rabinowits G
    type
    Author
  12. name
    Thai AA
    type
    Author
bibliography ids
  1. nci-bib-4407a770b2f0ec13c06547dd
book metadata
content sha256
59fd92e8048ddd339e7f6bffe2dbe2addb2f7d775fbe740af9951a778a3f4769
document type
citation
dois
  1. 10.1056/NEJMoa1805131
electronic publication date
display
2018 Jun 4
precision
day
year
2018
evidence scope
bibliographic_metadata_only
id
pubmed:29863979
immutable id
pubmed:29863979@59fd92e8048ddd339e7f6bffe2dbe2addb2f7d775fbe740af9951a778a3f4769
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
4
name
The New England journal of medicine
nlm unique id
0255562
pages
341-351
volume
379
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Rev Clin Oncol. 2018 Aug;15(8):472. doi: 10.1038/s41571-018-0056-5.
    note
    Source null
    related pmid
    29921845
    relationship
    Comment in
  2. citation
    Eye (Lond). 2023 Aug;37(12):2482-2487. doi: 10.1038/s41433-022-02358-y.
    note
    Source null
    related pmid
    36690728
    relationship
    Comment in
outcomes validated
false
pmid
29863979
provenance
batch id
c4c0356d060413f719c2
provider
NCBI PubMed ESummary
record sha256
edc4f19318bc26bd464b8895f6f523e6506907df1b4297b9fc50e66975286d0f
response sha256
adeb6beaad718f060a94981fd9e96a2eaddc4f781839549cb3e53cba822117c0
retrieved at
2026-09-09T23:47:33.674758+00:00
publication date
display
2018 Jul 26
precision
day
year
2018
publication types
  1. Clinical Trial, Phase I
  2. Clinical Trial, Phase II
  3. Journal Article
  4. Multicenter Study
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/29863979/
title
PD-1 Blockade with Cemiplimab in Advanced Cutaneous Squamous-Cell Carcinoma.

Preserved source evidence · Not medical advice